|
|
|
|
|
by bigchewy
3696 days ago
|
|
For those who haven't had a chance to read about the negative impact of testing, check out Atul Gawande's Overkill - http://www.newyorker.com/magazine/2015/05/11/overkill-atul-g... It explains why one of the most dangerous things for a healthy person to do is get tested. I've been in healthcare analytics for almost a decade now and see the same thing in the population data. Theranos and other pro-testers are usually well intentioned but fundamentally misguided and haven't looked at population wide data sets, which tell a different story. |
|
The decision to over-treat is part of the tradeoff we get when physicians are viewed as authority figures. Their inaction (not doing a treatment) is viewed as a delegitimization of the patient's needs, and so there is social pressure to treat, even when harm could be caused. This is a psychological blind spot that equally effects patient and physician.
But with respect to tests, so long as a test has a known false positive and false negative rate, its result can be accurately factored into a probabilistic model of a patient's overall health.
Our healthcare system is biased toward acute conditions and extreme interventions. Things like early disease progression and wellness are generally not even considered relevant to most doctors.
The reasoning approach of an evidence-based differential diagnosis which is taught to medical students is a powerful heuristic, but it is designed to work within the constraints of acute illness and (potentially) urgent intervention. So of course if fails when test results are considered without appropriate measures to improve the signal to noise ratio of the first branch of the decision tree.
With any kind of broad-spectrum, speculative testing, any result would need to be considered over time and in the context of many other factors. It is not a drop-in replacement for any step of the traditional differential.